Now Available: Women's Health Therapeutics, Analysis and Market Forecasts to 2016

New Pharmaceuticals research report from GBI Research is now available from Fast Market Research
 
Sept. 1, 2010 - PRLog -- GBI Research's report, "Women's Health Therapeutics Market to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis", provides in-depth analysis of unmet needs, drivers and barriers that impact the global women's health market. The report analyzes the markets for women's health in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

* Annualized market data for the women's health market from 2001 to 2009, forecast forward to 2016.
* Analysis of the leading therapeutic segments, including osteoporosis, hormone therapy for menopause, endometriosis, women's infertility and polycistic ovarian syndrome.
* Analysis of the women's health market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
* Market characterization of the women's health market, including market size, annual cost of therapy, sales volume and treatment usage patterns.
* Key drivers and barriers that have a significant impact on the market.
* Coverage of pipeline molecules in various phases of drug development.
* Competitive benchmarking of leading companies. The key companies studied in this report are Merck, Pfizer, Johnson & Johnson, Teva Pharmaceuticals and Bayer-Schering Pharma.
* Key M&A activities, licensing agreements, that have taken place in 2009 in the global blood disorders market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to

* Align your product portfolio to the markets with high growth potential.
* Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
* Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
* Develop key strategic initiatives by understanding the key focus areas of leading companies.
* Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/80738_womens_health_therapeuti...

Partial Table of Contents:

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Global WH Disorder Therapeutics Market:Introduction 10
2.1 GBI Research Report Guidance 10
3 Global WH Disorder Therapeutics Market: Market Characterization 11
3.1 Introduction 11
3.2 Revenue Forecasts for the Global WH Disorder Therapeutics Market 12
3.2.1 Sales Value 12
3.2.2 Annual Cost of Therapy 13
3.2.3 Treatment Usage Patterns 14
3.2.4 Generics' Share in the Global WH Disorder Therapeutics Market 20
4 Global WH Disorder Therapeutics Market: Therapeutic Landscape 21
4.1 Global Menopause Therapeutics Market 21
4.1.1 Introduction 21
4.1.2 Sales Value 21
4.1.3 Annual Cost of Therapy 23
4.1.4 Treatment Usage Patterns 24
4.1.5 Drivers and Barriers for the Menopause Therapeutics Market 30
4.1.6 Market share by Geography 31
4.1.7 Product Analysis 33
4.2 Global Endometriosis Therapeutics Market 38
4.2.1 Introduction 38
4.2.2 Sales Value 39
4.2.3 Annual Cost of Therapy 40
4.2.4 Treatment Usage Patterns 41
4.2.5 Drivers and Barriers for the Endometriosis Therapeutics Market 46
4.2.6 Market share by Geography 47
4.2.7 Product Analysis 48
4.3 Global Postmenopausal Osteoporosis (PMO) Market 51
4.3.1 Introduction 51
4.3.2 Sales Value 52
4.3.3 Annual Cost of Therapy 53
4.3.4 Treatment Usage Patterns 54
4.3.5 Drivers and Barriers for the Menopause Therapeutics Market 60
4.3.6 Market Share by Geography 61
4.3.7 Product Analysis 63
5 Global WH Disorder Therapeutics Market: Geographical Landscape 68
5.1 Geographical Break-up 68
5.2 The US 71
5.2.1 Sales Value 71
5.2.2 Annual Cost of Therapy 72
5.2.3 Treatment Usage Patterns 73
5.3 Top Five Markets in Europe 78
5.3.1 Sales Value 78
5.3.2 Annual Cost of Therapy 79
5.3.3 Treatment Usage Patterns 80
5.4 Japan 85
5.4.1 Sales Value 85
5.4.2 Annual Cost of Therapy 86
5.4.3 Treatment Usage Patterns 87
6 Global WH Disorder Therapeutics Market: Pipeline Analysis 92
6.1 Introduction 92
6.1.1 Research and Development Pipeline - Menopause 94
6.1.2 Research and Development Pipeline - Endometriosis 96
6.1.3 Research and Development Pipeline - Postmenopausal Osteoporosis 98
6.2 Profiles of Key Late-Stage Drugs in the WH disorder Therapeutics Market 101
6.2.1 Aprela (Bazedoxifene/Conjugated Estrogen) 101
6.2.2 Pristiq (Desvenlaxafine, DVS-233) 102
6.2.3 Visanne 103
6.2.4 Elagolix (NBI-56418) 103
6.2.5 Odanacatib (MK-0822) 104
6.2.6 Viviant (Bazedoxifene) 105
7 Global WH Disorder Therapeutics Market: Competitive Landscape 106
7.1 Market Share Analysis: Women's Health 106
7.2 Competitive Profiling 108
7.2.1 Pfizer Inc 108
7.3 Eli Lilly and Company 109
7.4 Merck & Co. 110
7.5 Procter & Gamble Company 112
7.6 Hoffmann-La Roche Ltd. 114
8 Global WH Disorder Therapeutics Market: Strategic Consolidations 117
8.1 Mergers and Acquisitions 117
8.1.1 Overview 117
8.1.2 Ferring Pharmaceuticals Acquires Global Rights to LYSTEDA from Xanodyne Pharmaceuticals in May 2010 121
8.1.3 BioSante Acquires Elestrin Royalty from Azur Pharma in March 2010 121
8.1.4 Teva-KOWA Pharma Acquires Majority Stake in Taisho Pharmaceutical in February 2010 121

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=8073...

About GBI Research

GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia.  View more research from GBI Research at http://www.fastmr.com/catalog/publishers.aspx?pubid=1016

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Therapeutic, wh, Disorder, 2001-2016, Treatment, Pipeline, Therapy, Menopause, Endometriosis, 2009-2016
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share